BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23874679)

  • 21. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered reactivity of central amygdala to GABA
    Lamirault C; Yu-Taeger L; Doyère V; Riess O; Nguyen HP; El Massioui N
    Neuropharmacology; 2017 Sep; 123():136-147. PubMed ID: 28587900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
    Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
    Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model.
    Cheong RY; Baldo B; Sajjad MU; Kirik D; Petersén Å
    Neuropathol Appl Neurobiol; 2021 Jun; 47(4):564-578. PubMed ID: 33330988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
    Hult Lundh S; Nilsson N; Soylu R; Kirik D; Petersén Å
    Hum Mol Genet; 2013 Sep; 22(17):3485-97. PubMed ID: 23697793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
    Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
    Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.
    Menalled L; El-Khodor BF; Patry M; Suárez-Fariñas M; Orenstein SJ; Zahasky B; Leahy C; Wheeler V; Yang XW; MacDonald M; Morton AJ; Bates G; Leeds J; Park L; Howland D; Signer E; Tobin A; Brunner D
    Neurobiol Dis; 2009 Sep; 35(3):319-36. PubMed ID: 19464370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease.
    Baldo B; Cheong RY; Petersén Å
    PLoS One; 2014; 9(10):e107691. PubMed ID: 25271967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.
    Kuljis DA; Gad L; Loh DH; MacDowell Kaswan Z; Hitchcock ON; Ghiani CA; Colwell CS
    PLoS One; 2016; 11(2):e0147583. PubMed ID: 26871695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease.
    Kirch RD; Meyer PT; Geisler S; Braun F; Gehrig S; Langen KJ; von Hörsten S; Nikkhah G; Cassel JC; Döbrössy MD
    Behav Brain Res; 2013 Feb; 239():15-26. PubMed ID: 23137697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels.
    Yu-Taeger L; Bonin M; Stricker-Shaver J; Riess O; Nguyen HHP
    Neuropharmacology; 2017 May; 117():260-272. PubMed ID: 28153533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington's disease knock-in mice.
    Brooks S; Higgs G; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):182-8. PubMed ID: 20457230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Rising AC; Xu J; Carlson A; Napoli VV; Denovan-Wright EM; Mandel RJ
    Exp Neurol; 2011 Apr; 228(2):173-82. PubMed ID: 21192926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significantly differential diffusion of neuropathological aggregates in the brain of transgenic mice carrying N-terminal mutant huntingtin fused with green fluorescent protein.
    Cheng PH; Li CL; Her LS; Chang YF; Chan AW; Chen CM; Yang SH
    Brain Struct Funct; 2013 Jan; 218(1):283-94. PubMed ID: 22422149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capturing schizophrenia-like prodromal symptoms in a spinocerebellar ataxia-17 transgenic rat.
    Amato D; Canneva F; Nguyen HP; Bauer P; Riess O; von Hörsten S; Müller CP
    J Psychopharmacol; 2017 Apr; 31(4):461-473. PubMed ID: 27856682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memory deficits in the transgenic rat model of Huntington's disease.
    Zeef DH; van Goethem NP; Vlamings R; Schaper F; Jahanshahi A; Hescham S; von Hörsten S; Prickaerts J; Temel Y
    Behav Brain Res; 2012 Feb; 227(1):194-8. PubMed ID: 22101303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BACHD rat model of Huntington disease shows slowed learning in a Go/No-Go-like test of visual discrimination.
    Clemensson EKH; Novati A; Clemensson LE; Riess O; Nguyen HP
    Behav Brain Res; 2019 Feb; 359():116-126. PubMed ID: 30385368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.